Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
20 "Genetic"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Type 1 Diabetes
A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms
Sophie Welsch, Antoine Harvengt, Paola Gallo, Manon Martin, Dominique Beckers, Thierry Mouraux, Nicole Seret, Marie-Christine Lebrethon, Raphaël Helaers, Pascal Brouillard, Miikka Vikkula, Philippe A. Lysy
Received May 26, 2023  Accepted November 25, 2023  Published online March 22, 2024  
DOI: https://doi.org/10.4093/dmj.2023.0166    [Epub ahead of print]
  • 863 View
  • 55 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Recent diabetes subclassifications have improved the differentiation between patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus despite several overlapping features, yet without considering genetic forms of diabetes. We sought to facilitate the identification of monogenic diabetes by creating a new tool that we validated in a pediatric maturity-onset diabetes of the young (MODY) cohort.
Methods
We first created the DIAgnose MOnogenic DIAbetes (DIAMODIA) criteria based on the pre-existing, but incomplete, MODY calculator. This new score is composed of four strong and five weak criteria, with patients having to display at least one weak and one strong criterion.
Results
The effectiveness of the DIAMODIA criteria was evaluated in two patient cohorts, the first consisting of patients with confirmed MODY diabetes (n=34) and the second of patients with T1DM (n=390). These DIAMODIA criteria successfully detected 100% of MODY patients. Multiple correspondence analysis performed on the MODY and T1DM cohorts enabled us to differentiate MODY patients from T1DM. The three most relevant variables to distinguish a MODY from T1DM profile were: lower insulin-dose adjusted A1c score ≤9, glycemic target-adjusted A1c score ≤4.5, and absence of three anti-islet cell autoantibodies.
Conclusion
We validated the DIAMODIA criteria, as it effectively identified all monogenic diabetes patients (MODY cohort) and succeeded to differentiate T1DM from MODY patients. The creation of this new and effective tool is likely to facilitate the characterization and therapeutic management of patients with atypical diabetes, and promptly referring them for genetic testing which would markedly improve clinical care and counseling, as well.
Brief Report
Genetics
Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea
Eun Hoo Rho, Sang Ik Baek, Heerah Lee, Moon-Woo Seong, Jong-Hee Chae, Kyong Soo Park, Soo Heon Kwak
Received March 10, 2023  Accepted July 20, 2023  Published online February 1, 2024  
DOI: https://doi.org/10.4093/dmj.2023.0078    [Epub ahead of print]
  • 534 View
  • 32 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Maternally inherited diabetes and deafness (MIDD) is a rare mitochondrial disorder primarily resulting from m.3243A>G mutation. The clinical characteristics of MIDD exhibit significant heterogeneity. Our study aims to delineate these characteristics and determine the potential correlation with m.3243A>G heteroplasmy levels. This retrospective, descriptive study encompassed patients with confirmed m.3243A>G mutation and diabetes mellitus at Seoul National University Hospital. Our cohort comprises 40 patients with MIDD, with a mean age at study enrollment of 33.3±12.9 years and an average % of heteroplasmy of 30.0%± 14.6% in the peripheral blood. The most prevalent comorbidity was hearing loss (90%), followed by albuminuria (61%), seizure (38%), and stroke (33%). We observed a significant negative correlation between % of heteroplasmy and age at diabetes diagnosis. These clinical features can aid in the suspicion of MIDD and further consideration of genetic testing for m.3243A>G mutation.
Review
Complications
Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions
Md Jakir Hossain, Michael D. Kendig, Meg E. Letton, Margaret J. Morris, Ria Arnold
Diabetes Metab J. 2022;46(2):198-221.   Published online March 24, 2022
DOI: https://doi.org/10.4093/dmj.2021.0347
  • 5,248 View
  • 225 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFPubReader   ePub   
Diabetic peripheral neuropathy (DPN) affects over half of type 2 diabetes mellitus (T2DM) patients, with an urgent need for effective pharmacotherapies. While many rat and mouse models of T2DM exist, the phenotyping of DPN has been challenging with inconsistencies across laboratories. To better characterize DPN in rodents, a consensus guideline was published in 2014 to accelerate the translation of preclinical findings. Here we review DPN phenotyping in rat models of T2DM against the ‘Neurodiab’ criteria to identify uptake of the guidelines and discuss how DPN phenotypes differ between models and according to diabetes duration and sex. A search of PubMed, Scopus and Web of Science databases identified 125 studies, categorised as either diet and/or chemically induced models or transgenic/spontaneous models of T2DM. The use of diet and chemically induced T2DM models has exceeded that of transgenic models in recent years, and the introduction of the Neurodiab guidelines has not appreciably increased the number of studies assessing all key DPN endpoints. Combined high-fat diet and low dose streptozotocin rat models are the most frequently used and well characterised. Overall, we recommend adherence to Neurodiab guidelines for creating better animal models of DPN to accelerate translation and drug development.

Citations

Citations to this article as recorded by  
  • SIRT3 alleviates painful diabetic neuropathy by mediating the FoxO3a‐PINK1‐Parkin signaling pathway to activate mitophagy
    Jing Yang, Zhuoying Yu, Ye Jiang, Zixian Zhang, Yue Tian, Jie Cai, Min Wei, Yanhan Lyu, Dongsheng Yang, Shixiong Shen, Guo‐Gang Xing, Min Li
    CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
  • Compound Qiying Granules alleviates diabetic peripheral neuropathy by inhibiting endoplasmic reticulum stress and apoptosis
    Yan Hu, Chen Chen, Zhengting Liang, Tao Liu, Xiaoling Hu, Guanying Wang, Jinxia Hu, Xiaolin Xie, Zhiyan Liu
    Molecular Medicine.2023;[Epub]     CrossRef
  • HCV affects KATP channels through GnT-IVa-mediated N-glycosylation of GLUT2 on the surface of pancreatic β-cells leading to impaired insulin secretion
    Ben Niu, Lijing Ma, Lixuan Yao, Yating Zhang, Heng Su
    Endocrine.2023;[Epub]     CrossRef
  • Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
    Annalisa Canta, Valentina A. Carozzi, Alessia Chiorazzi, Cristina Meregalli, Norberto Oggioni, Virginia Rodriguez-Menendez, Barbara Sala, Roberto Cosimo Melcangi, Silvia Giatti, Raffaella Lombardi, Roberto Bianchi, Paola Marmiroli, Guido Cavaletti
    Biomedicines.2022; 11(1): 20.     CrossRef
Original Articles
Basic Research
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
Lili Kong, Hongyue Wang, Chenhao Li, Huiyan Cheng, Yan Cui, Li Liu, Ying Zhao
Diabetes Metab J. 2021;45(6):909-920.   Published online June 4, 2021
DOI: https://doi.org/10.4093/dmj.2020.0168
  • 5,443 View
  • 141 Download
  • 17 Web of Science
  • 19 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Background
The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis.
Methods
Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis.
Results
SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro.
Conclusion
Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.

Citations

Citations to this article as recorded by  
  • Sulforaphane reduces adipose tissue fibrosis via promoting M2 macrophages polarization in HFD fed-mice
    Zhenzhen Zhang, Huali Chen, Cheng Pan, Rui Li, Wangsheng Zhao, Tianzeng Song
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119626.     CrossRef
  • Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
    Patrícia dos Santos Azeredo, Daping Fan, E. Angela Murphy, Wayne E. Carver
    Cells.2024; 13(5): 421.     CrossRef
  • Beneficial role of broccoli and its active ingredient, sulforaphane in the treatment of diabetes
    Aminu Mohammed, Hafsat Abdullahi Mohammed
    Phytomedicine Plus.2023; 3(2): 100431.     CrossRef
  • The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
    Christodoula Kourtidou, Konstantinos Tziomalos
    International Journal of Molecular Sciences.2023; 24(6): 6007.     CrossRef
  • Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
    Da-Wei Lin, Yung-Chien Hsu, Cheng-Chih Chang, Ching-Chuan Hsieh, Chun-Liang Lin
    International Journal of Molecular Sciences.2023; 24(7): 6053.     CrossRef
  • Beneficial Effects of Sulforaphane on Diabetes and Its Complications via Both Nrf2-Dependent and Independent Mechanisms
    Minhyuk Kim, Joo Young Lee
    Food Supplements and Biomaterials for Health.2023;[Epub]     CrossRef
  • Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: A systematic review and meta-analysis
    Elisa B. Monteiro, Matheus Ajackson, Milena B. Stockler-Pinto, Fitsum Guebre-Egziabher, Julio B. Daleprane, Christophe O. Soulage
    Life Sciences.2023; 322: 121664.     CrossRef
  • Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway
    Hongzhou Lin, Huihui Chen, Rengcheng Qian, Guoqi Tang, Yinjuan Ding, Yalan Jiang, Congde Chen, Dexuan Wang, Maoping Chu, Xiaoling Guo
    Chemico-Biological Interactions.2023; 382: 110559.     CrossRef
  • Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
    Tao Jiang, Yuhe Dong, Wanying Zhu, Tong Wu, Linyan Chen, Yuantong Cao, Xi Yu, Ye Peng, Ling Wang, Ying Xiao, Tian Zhong
    Critical Reviews in Food Science and Nutrition.2023; : 1.     CrossRef
  • Sulforaphane: A nutraceutical against diabetes-related complications
    Sinenhlanhla X.H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Sonia Silvestri, Patrick Orlando, Bongani B. Nkambule, Christo J.F. Muller, Duduzile Ndwandwe, Albertus K. Basson, Luca Tiano, Phiwayinkosi V. Dludla
    Pharmacological Research.2023; 196: 106918.     CrossRef
  • Nrf2/HO-1 as a therapeutic target in renal fibrosis
    Emad H.M. Hassanein, Islam M. Ibrahim, Esraa K. Abd-alhameed, Zeina W. Sharawi, Fatima A. Jaber, Hanan S. Althagafy
    Life Sciences.2023; 334: 122209.     CrossRef
  • A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications
    Neda Mohamadi, Vafa Baradaran Rahimi, Mohammad Reza Fadaei, Fatemeh Sharifi, Vahid Reza Askari
    Inflammopharmacology.2023; 31(6): 2885.     CrossRef
  • The HDAC2/SP1/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease
    Zongji Zheng, Shuting Zhang, Jiaqi Chen, Meina Zou, Yanlin Yang, Wen Lu, Shijing Ren, Xiangyu Wang, Wenhui Dong, Zikun Zhang, Ling Wang, Meiping Guan, Gladys L.Y. Cheing, Yaoming Xue, Yijie Jia
    Clinical Science.2022; 136(3): 223.     CrossRef
  • BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
    Yawen Xiao, Dan Liang, Zhiyang Li, Zhaowei Feng, Zhiping Yuan, Fan Zhang, Yuanyuan Wang, Yuxia Zhou, Mingjun Shi, Lingling Liu, Ying Xiao, Bing Guo
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation
    Chun Ouyang, Lei Huang, Xiaoqiang Ye, Mingming Ren, Zhen Han
    Experimental and Clinical Endocrinology & Diabetes.2022; 130(10): 660.     CrossRef
  • Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
    Jialu Li, Chao Yu, Fengchen Shen, Binbin Cui, Na Liu, Shougang Zhuang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
    Jiayu Wang, Jiaxing Li, Xin Zhang, Min Zhang, Xiaopeng Hu, Hang Yin
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
    Mengjiao Wang, Min Chen, Rui Guo, Yangyang Ding, Haihui Zhang, Yuanqing He
    Trends in Food Science & Technology.2022; 129: 397.     CrossRef
  • Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
    Hao Yan, Jiangxin Xu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He
    Biomedicine & Pharmacotherapy.2021; 143: 112115.     CrossRef
Genetics
The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus
Felipe Mateus Pellenz, Cristine Dieter, Guilherme Coutinho Kullmann Duarte, Luís Henrique Canani, Bianca Marmontel de Souza, Daisy Crispim
Diabetes Metab J. 2021;45(6):899-908.   Published online May 24, 2021
DOI: https://doi.org/10.4093/dmj.2020.0194
  • 4,773 View
  • 157 Download
  • 1 Web of Science
  • 3 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Background
Tyrosine kinase 2 (TYK2) is a candidate gene for type 1 diabetes mellitus (T1DM) since it plays an important role in regulating apoptotic and pro-inflammatory pathways in pancreatic β-cells through modulation of the type I interferon signaling pathway. The rs2304256 single nucleotide polymorphism (SNP) in TYK2 gene has been associated with protection for different autoimmune diseases. However, to date, only two studies have evaluated the association between this SNP and T1DM, with discordant results. This study thus aimed to investigate the association between the TYK2 rs2304256 SNP and T1DM in a Southern Brazilian population.
Methods
This case-control study comprised 478 patients with T1DM and 518 non-diabetic subjects. The rs2304256 (C/A) SNP was genotyped by real-time polymerase chain reaction technique using TaqMan minor groove binder (MGB) probes.
Results
Genotype and allele frequencies of the rs2304256 SNP differed between T1DM patients and non-diabetic subjects (P<0.0001 and P=0.001, respectively). Furthermore, the A allele was associated with protection against T1DM under recessive (odds ratio [OR], 0.482; 95% confidence interval [CI], 0.288 to 0.806) and additive (OR, 0.470; 95% CI, 0.278 to 0.794) inheritance models, adjusting for human leukocyte antigen (HLA) DR/DQ genotypes, gender, and ethnicity.
Conclusion
The A/A genotype of TYK2 rs2304256 SNP is associated with protection against T1DM in a Southern Brazilian population.

Citations

Citations to this article as recorded by  
  • Associations of genetic variants within TYK2 with pulmonary tuberculosis among Chinese population
    Mingwu Zhang, Zhengwei Liu, Yelei Zhu, Kunyang Wu, Lin Zhou, Ying Peng, Junhang Pan, Bin Chen, Xiaomeng Wang, Songhua Chen
    Molecular Genetics & Genomic Medicine.2024;[Epub]     CrossRef
  • Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort
    Maria Skerenova, Michal Cibulka, Zuzana Dankova, Veronika Holubekova, Zuzana Kolkova, Vincent Lucansky, Dana Dvorska, Andrea Kapinova, Michaela Krivosova, Martin Petras, Eva Baranovicova, Ivana Baranova, Elena Novakova, Peter Liptak, Peter Banovcin, Anna
    Advances in Medical Sciences.2024; 69(1): 198.     CrossRef
  • Cross-Domain Text Mining of Pathophysiological Processes Associated with Diabetic Kidney Disease
    Krutika Patidar, Jennifer H. Deng, Cassie S. Mitchell, Ashlee N. Ford Versypt
    International Journal of Molecular Sciences.2024; 25(8): 4503.     CrossRef
Genetics
Association of Combined TCF7L2 and KCNQ1 Gene Polymorphisms with Diabetic Micro- and Macrovascular Complications in Type 2 Diabetes Mellitus
Rujikorn Rattanatham, Nongnuch Settasatian, Nantarat Komanasin, Upa Kukongviriyapan, Kittisak Sawanyawisuth, Phongsak Intharaphet, Vichai Senthong, Chatri Settasatian
Diabetes Metab J. 2021;45(4):578-593.   Published online March 22, 2021
DOI: https://doi.org/10.4093/dmj.2020.0101
  • 5,634 View
  • 147 Download
  • 8 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Vascular complications are the major morbid consequences of type 2 diabetes mellitus (T2DM). The transcription factor 7-like 2 (TCF7L2), potassium voltage-gated channel subfamily Q member 1 (KCNQ1), and inwardly-rectifying potassium channel, subfamily J, member 11 gene (KCNJ11) are common T2DM susceptibility genes in various populations. However, the associations between polymorphisms in these genes and diabetic complications are controversial. This study aimed to investigate the effects of combined gene-polymorphisms within TCF7L2, KCNQ1, and KCNJ11 on vascular complications in Thai subjects with T2DM.
Methods
We conducted a case-control study comprising 960 T2DM patients and 740 non-diabetes controls. Single nucleotide polymorphisms in TCF7L2, KCNQ1, and KCNJ11 were genotyped and evaluated for their association with diabetic vascular complications.
Results
The gene variants TCF7L2 rs290487-T, KCNQ1 rs2237892-C, and KCNQ1 rs2237897-C were associated with increased risk of T2DM. TCF7L2 rs7903146-C, TCF7L2 rs290487-C, KCNQ1 rs2237892-T, and KCNQ1 rs2237897-T revealed an association with hypertension. The specific combination of risk-alleles that have effects on T2DM and hypertension, TCF7L2 rs7903146-C, KCNQ1 rs2237892-C, and KCNQ1 rs2237897-T, as genetic risk score (GRS), pronounced significant association with coronary artery disease (CAD), cumulative nephropathy and CAD, and cumulative microvascular and macrovascular complications (respective odds ratios [ORs] with 95% confidence interval [95% CI], comparing between GRS 2–3 and GRS 5–6, were 7.31 [2.03 to 26.35], 3.92 [1.75 to 8.76], and 2.33 [1.13 to 4.79]).
Conclusion
This study demonstrated, for the first time, the effect conferred by specific combined genetic variants in TCF7L2 and KCNQ1 on diabetic vascular complications, predominantly with nephropathy and CAD. Such a specific pattern of gene variant combination may implicate in the progression of T2DM and life-threatening vascular complications.

Citations

Citations to this article as recorded by  
  • Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review
    Aleena Shujaat Ali, Cecilia Pham, Grant Morahan, Elif Ilhan Ekinci
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(5): 1189.     CrossRef
  • Saudi Community-Based Screening Study on Genetic Variants in β-Cell Dysfunction and Its Role in Women with Gestational Diabetes Mellitus
    Amal F. Alshammary, Malak Mohammed Al-Hakeem, Imran Ali Khan
    Genes.2023; 14(4): 924.     CrossRef
  • Association between KCNJ11 E23K polymorphism and the risk of type 2 diabetes mellitus: A global meta-analysis
    Yaxuan Ren, Wenfei Zhu, Jikang Shi, Aiyu Shao, Yi Cheng, Yawen Liu
    Journal of Diabetes and its Complications.2022; 36(5): 108170.     CrossRef
  • Association between carotid atherosclerosis and presence of intracranial atherosclerosis using three-dimensional high-resolution vessel wall magnetic resonance imaging in asymptomatic patients with type 2 diabetes
    Ji Eun Jun, You-Cheol Hwang, Kyu Jeong Ahn, Ho Yeon Chung, Geon-Ho Jahng, Soonchan Park, In-Kyung Jeong, Chang-Woo Ryu
    Diabetes Research and Clinical Practice.2022; 191: 110067.     CrossRef
  • Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus
    Yu-Ting Hsiao, Feng-Chih Shen, Shao-Wen Weng, Pei-Wen Wang, Yung-Jen Chen, Jong-Jer Lee
    Journal of Personalized Medicine.2021; 11(8): 689.     CrossRef
  • Oxidative Stress Genes in Diabetes Mellitus Type 2: Association with Diabetic Kidney Disease
    Athanasios Roumeliotis, Stefanos Roumeliotis, Fotis Tsetsos, Marianthi Georgitsi, Panagiotis I. Georgianos, Aikaterini Stamou, Anna Vasilakou, Kalliopi Kotsa, Xanthippi Tsekmekidou, Peristera Paschou, Stylianos Panagoutsos, Vassilios Liakopoulos, Elena Az
    Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
  • Analysis of the association of polymorphisms of genes markers functions of endothelium and vascular-plate hemostasis with development of diabetic foot syndrome
    N. I. Troitskaya, K. G. Shapovalov, V. A. Mudrov
    Acta Biomedica Scientifica.2021; 6(4): 18.     CrossRef
Review
Genetics
Update on Monogenic Diabetes in Korea
Ye Seul Yang, Soo Heon Kwak, Kyong Soo Park
Diabetes Metab J. 2020;44(5):627-639.   Published online October 21, 2020
DOI: https://doi.org/10.4093/dmj.2020.0214
  • 6,646 View
  • 243 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   
Monogenic diabetes, including maturity-onset diabetes of the young, neonatal diabetes, and other rare forms of diabetes, results from a single gene mutation. It has been estimated to represent around 1% to 6% of all diabetes. With the advances in genome sequencing technology, it is possible to diagnose more monogenic diabetes cases than ever before. In Korea, 11 studies have identified several monogenic diabetes cases, using Sanger sequencing and whole exome sequencing since 2001. The recent largest study, using targeted exome panel sequencing, found a molecular diagnosis rate of 21.1% for monogenic diabetes in clinically suspected patients. Mutations in glucokinase (GCK), hepatocyte nuclear factor 1α (HNF1A), and HNF4A were most commonly found. Genetic diagnosis of monogenic diabetes is important as it determines the therapeutic approach required for patients and helps to identify affected family members. However, there are still many challenges, which include a lack of simple clinical criterion for selecting patients for genetic testing, difficulties in interpreting the genetic test results, and high costs for genetic testing. In this review, we will discuss the latest updates on monogenic diabetes in Korea, and suggest an algorithm to screen patients for genetic testing. The genetic tests and non-genetic markers for accurate diagnosis of monogenic diabetes will be also reviewed.

Citations

Citations to this article as recorded by  
  • Targeted gene panel analysis of Japanese patients with maturity‐onset diabetes of the young‐like diabetes mellitus: Roles of inactivating variants in the ABCC8 and insulin resistance genes
    Tohru Yorifuji, Yoh Watanabe, Kana Kitayama, Yuki Yamada, Shinji Higuchi, Jun Mori, Masaru Kato, Toru Takahashi, Tokuko Okuda, Takane Aoyama
    Journal of Diabetes Investigation.2023; 14(3): 387.     CrossRef
  • Efficacy of acupuncture on cardiovascular complications in patients with diabetes mellitus in Korea: A nationwide retrospective cohort
    Hyejin Jung, Tiana Won, Ga-Yeon Kim, Jowon Jang, Sujung Yeo, Sabina Lim
    Journal of Integrative Medicine.2023; 21(2): 176.     CrossRef
  • Identification of rare variants in candidate genes associated with monogenic diabetes in polish mody-x patients
    Paulina Jakiel, K. Gadzalska, E. Juścińska, M. Gorządek, T. Płoszaj, S. Skoczylas, M. Borowiec, A. Zmysłowska
    Journal of Diabetes & Metabolic Disorders.2023;[Epub]     CrossRef
  • Genetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions
    Hong-Yan Sun, Xiao-Yan Lin
    World Journal of Diabetes.2023; 14(12): 1738.     CrossRef
  • Maturity-Onset Diabetes of the Young (MODY)
    Seung Shin Park, Soo Heon Kwak
    The Journal of Korean Diabetes.2022; 23(3): 157.     CrossRef
  • The Genetic Spectrum of Maturity-Onset Diabetes of the Young (MODY) in Qatar, a Population-Based Study
    Asma A. Elashi, Salman M. Toor, Ilhame Diboun, Yasser Al-Sarraj, Shahrad Taheri, Karsten Suhre, Abdul Badi Abou-Samra, Omar M. E. Albagha
    International Journal of Molecular Sciences.2022; 24(1): 130.     CrossRef
  • Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
    Ye Seul Yang, Tae Seo Sohn
    Diabetes & Metabolism Journal.2021; 45(2): 277.     CrossRef
  • Sequencing Cell-free Fetal DNA in Pregnant Women With GCK-MODY
    Soo Heon Kwak, Camille E Powe, Se Song Jang, Michael J Callahan, Sarah N Bernstein, Seung Mi Lee, Sunyoung Kang, Kyong Soo Park, Hak C Jang, Jose C Florez, Jong-Il Kim, Jong Hee Chae
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(9): 2678.     CrossRef
  • Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
    Bo Kyung Koo, Seoil Moon, Min Kyong Moon
    BMC Geriatrics.2021;[Epub]     CrossRef
  • A rare, likely pathogenic GCK variant related to maturity-onset diabetes of the young type 2: A case report
    Min-Kyung So, Jungwon Huh, Hae Soon Kim
    Journal of Genetic Medicine.2021; 18(2): 132.     CrossRef
Original Articles
Genetics
Exome Chip Analysis of 14,026 Koreans Reveals Known and Newly Discovered Genetic Loci Associated with Type 2 Diabetes Mellitus
Seong Beom Cho, Jin Hwa Jang, Myung Guen Chung, Sang Cheol Kim
Diabetes Metab J. 2021;45(2):231-240.   Published online July 28, 2020
DOI: https://doi.org/10.4093/dmj.2019.0163
  • 6,247 View
  • 195 Download
  • 6 Web of Science
  • 6 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Most loci associated with type 2 diabetes mellitus (T2DM) discovered to date are within noncoding regions of unknown functional significance. By contrast, exonic regions have advantages for biological interpretation.

Methods

We analyzed the association of exome array data from 14,026 Koreans to identify susceptible exonic loci for T2DM. We used genotype information of 50,543 variants using the Illumina exome array platform.

Results

In total, 7 loci were significant with a Bonferroni adjusted P=1.03×10−6. rs2233580 in paired box gene 4 (PAX4) showed the highest odds ratio of 1.48 (P=1.60×10−10). rs11960799 in membrane associated ring-CH-type finger 3 (MARCH3) and rs75680863 in transcobalamin 2 (TCN2) were newly identified loci. When we built a model to predict the incidence of diabetes with the 7 loci and clinical variables, area under the curve (AUC) of the model improved significantly (AUC=0.72, P<0.05), but marginally in its magnitude, compared with the model using clinical variables (AUC=0.71, P<0.05). When we divided the entire population into three groups—normal body mass index (BMI; <25 kg/m2), overweight (25≤ BMI <30 kg/m2), and obese (BMI ≥30 kg/m2) individuals—the predictive performance of the 7 loci was greatest in the group of obese individuals, where the net reclassification improvement was highly significant (0.51; P=8.00×10−5).

Conclusion

We found exonic loci having a susceptibility for T2DM. We found that such genetic information is advantageous for predicting T2DM in a subgroup of obese individuals.

Citations

Citations to this article as recorded by  
  • Polygenic Risk Score, Lifestyles, and Type 2 Diabetes Risk: A Prospective Chinese Cohort Study
    Jia Liu, Lu Wang, Xuan Cui, Qian Shen, Dun Wu, Man Yang, Yunqiu Dong, Yongchao Liu, Hai Chen, Zhijie Yang, Yaqi Liu, Meng Zhu, Hongxia Ma, Guangfu Jin, Yun Qian
    Nutrients.2023; 15(9): 2144.     CrossRef
  • Celebrities in the heart, strangers in the pancreatic beta cell: Voltage‐gated potassium channels Kv7.1 and Kv11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes
    Anniek F. Lubberding, Christian R. Juhl, Emil Z. Skovhøj, Jørgen K. Kanters, Thomas Mandrup‐Poulsen, Signe S. Torekov
    Acta Physiologica.2022;[Epub]     CrossRef
  • Substitution of Carbohydrates for Fats and Risk of Type 2 Diabetes among Korean Middle-Aged Adults: Findings from the Korean Genome and Epidemiology Study
    Hye-Ah Lee, Hyesook Park
    Nutrients.2022; 14(3): 654.     CrossRef
  • Ethnic-Specific Type 2 Diabetes Risk Factor PAX4 R192H Is Associated with Attention-Specific Cognitive Impairment in Chinese with Type 2 Diabetes
    Su Fen Ang, Serena Low, Tze Pin Ng, Clara S.H. Tan, Keven Ang, Ziliang Lim, Wern Ee Tang, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim, Nagaendran Kandiah
    Journal of Alzheimer's Disease.2022; 88(1): 241.     CrossRef
  • TrustGWAS: A full-process workflow for encrypted GWAS using multi-key homomorphic encryption and pseudorandom number perturbation
    Meng Yang, Chuwen Zhang, Xiaoji Wang, Xingmin Liu, Shisen Li, Jianye Huang, Zhimin Feng, Xiaohui Sun, Fang Chen, Shuang Yang, Ming Ni, Lin Li, Yanan Cao, Feng Mu
    Cell Systems.2022; 13(9): 752.     CrossRef
  • Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
    Hye Ah Lee, Hyesook Park, Young Sun Hong
    Diabetes & Metabolism Journal.2022; 46(6): 879.     CrossRef
Genetics
Enhancer-Gene Interaction Analyses Identified the Epidermal Growth Factor Receptor as a Susceptibility Gene for Type 2 Diabetes Mellitus
Yang Yang, Shi Yao, Jing-Miao Ding, Wei Chen, Yan Guo
Diabetes Metab J. 2021;45(2):241-250.   Published online June 10, 2020
DOI: https://doi.org/10.4093/dmj.2019.0204
  • 6,050 View
  • 104 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Genetic interactions are known to play an important role in the missing heritability problem for type 2 diabetes mellitus (T2DM). Interactions between enhancers and their target genes play important roles in gene regulation and disease pathogenesis. In the present study, we aimed to identify genetic interactions between enhancers and their target genes associated with T2DM.

Methods

We performed genetic interaction analyses of enhancers and protein-coding genes for T2DM in 2,696 T2DM patients and 3,548 controls of European ancestry. A linear regression model was used to identify single nucleotide polymorphism (SNP) pairs that could affect the expression of the protein-coding genes. Differential expression analyses were used to identify differentially expressed susceptibility genes in diabetic and nondiabetic subjects.

Results

We identified one SNP pair, rs4947941×rs7785013, significantly associated with T2DM (combined P=4.84×10−10). The SNP rs4947941 was annotated as an enhancer, and rs7785013 was located in the epidermal growth factor receptor (EGFR) gene. This SNP pair was significantly associated with EGFR expression in the pancreas (P=0.033), and the minor allele “A” of rs7785013 decreased EGFR gene expression and the risk of T2DM with an increase in the dosage of “T” of rs4947941. EGFR expression was significantly upregulated in T2DM patients, which was consistent with the effect of rs4947941×rs7785013 on T2DM and EGFR expression. A functional validation study using the Mouse Genome Informatics (MGI) database showed that EGFR was associated with diabetes-relevant phenotypes.

Conclusion

Genetic interaction analyses of enhancers and protein-coding genes suggested that EGFR may be a novel susceptibility gene for T2DM.

Citations

Citations to this article as recorded by  
  • Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
    Dandan Chen, Jin Li, Hongwei Liu, Xiaolong Liu, Chenghao Zhang, Haoran Luo, Yiming Wei, Yang Xi, Hong Liang, Qiushi Zhang
    Genes.2023; 14(7): 1322.     CrossRef
  • Investigation of the mechanism of Shen Qi Wan prescription in the treatment of T2DM via network pharmacology and molecular docking
    Piaopiao Zhao, Xiaoxiao Zhang, Yuning Gong, Weihua Li, Zengrui Wu, Yun Tang, Guixia Liu
    In Silico Pharmacology.2022;[Epub]     CrossRef
  • The Role of the Epidermal Growth Factor Receptor in Diabetic Kidney Disease
    Raymond C. Harris
    Cells.2022; 11(21): 3416.     CrossRef
  • Co-expression Network Revealed Roles of RNA m6A Methylation in Human β-Cell of Type 2 Diabetes Mellitus
    Cong Chen, Qing Xiang, Weilin Liu, Shengxiang Liang, Minguang Yang, Jing Tao
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
Reviews
Basic Research
Role of CRTC2 in Metabolic Homeostasis: Key Regulator of Whole-Body Energy Metabolism?
Hye-Sook Han, Yongmin Kwon, Seung-Hoi Koo
Diabetes Metab J. 2020;44(4):498-508.   Published online March 5, 2020
DOI: https://doi.org/10.4093/dmj.2019.0200
  • 6,997 View
  • 163 Download
  • 14 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   

Cyclic adenosine monophosphate (cAMP) signaling is critical for regulating metabolic homeostasis in mammals. In particular, transcriptional regulation by cAMP response element-binding protein (CREB) and its coactivator, CREB-regulated transcription coactivator (CRTC), is essential for controlling the expression of critical enzymes in the metabolic process, leading to more chronic changes in metabolic flux. Among the CRTC isoforms, CRTC2 is predominantly expressed in peripheral tissues and has been shown to be associated with various metabolic pathways in tissue-specific manners. While initial reports showed the physiological role of CRTC2 in regulating gluconeogenesis in the liver, recent studies have further delineated the role of this transcriptional coactivator in the regulation of glucose and lipid metabolism in various tissues, including the liver, pancreatic islets, endocrine tissues of the small intestines, and adipose tissues. In this review, we discuss recent studies that have utilized knockout mouse models to delineate the role of CRTC2 in the regulation of metabolic homeostasis.

Citations

Citations to this article as recorded by  
  • Integration of genomic and transcriptomic data of inbred mouse models for polygenic obesity and leanness revealed “obese” and “lean” candidate alleles in polyadenylation signals
    Martin Šimon, Špela Mikec, Nicholas M. Morton, Santosh S. Atanur, Simon Horvat, Tanja Kunej
    Gene Reports.2024; 35: 101903.     CrossRef
  • Mylabris phalerata induces the apoptosis and cell cycle delay in HCC, and potentiates the effect of sorafenib based on the molecular and network pharmacology approach
    Young Woo Kim, Seon Been Bak, Su Youn Baek, Il Kon Kim, Won-Yung Lee, Un-Jung Yun, Kwang-Il Park
    Molecular & Cellular Toxicology.2023; 19(4): 731.     CrossRef
  • Emerging Role of SMILE in Liver Metabolism
    Nanthini Sadasivam, Kamalakannan Radhakrishnan, Hueng-Sik Choi, Don-Kyu Kim
    International Journal of Molecular Sciences.2023; 24(3): 2907.     CrossRef
  • PIMT regulates hepatic gluconeogenesis in mice
    Bandish Kapadia, Soma Behera, Sireesh T. Kumar, Tapan Shah, Rebecca Kristina Edwin, Phanithi Prakash Babu, Partha Chakrabarti, Kishore V.L. Parsa, Parimal Misra
    iScience.2023; 26(3): 106120.     CrossRef
  • Biological functions of CRTC2 and its role in metabolism-related diseases
    Hong-Yu Zheng, Yan-Xia Wang, Kun Zhou, Hai-Lin Xie, Zhong Ren, Hui-Ting Liu, Yang-Shao Ou, Zhi-Xiang Zhou, Zhi-Sheng Jiang
    Journal of Cell Communication and Signaling.2023; 17(3): 495.     CrossRef
  • An insulin-regulated arrestin domain protein controls hepatic glucagon action
    Sezin Dagdeviren, Megan F. Hoang, Mohsen Sarikhani, Vanessa Meier, Jake C. Benoit, Marinna C. Okawa, Veronika Y. Melnik, Elisabeth M. Ricci-Blair, Natalie Foot, Randall H. Friedline, Xiaodi Hu, Lauren A. Tauer, Arvind Srinivasan, Maxim B. Prigozhin, Sudha
    Journal of Biological Chemistry.2023; 299(8): 105045.     CrossRef
  • The Pleiotropic Face of CREB Family Transcription Factors
    Md. Arifur Rahman Chowdhury, Jungeun An, Sangyun Jeong
    Molecules and Cells.2023; 46(7): 399.     CrossRef
  • It is a branched road to adipose tissue aging
    N. Touitou, B. Lerrer, H. Y. Cohen
    Nature Aging.2023; 3(8): 911.     CrossRef
  • Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement
    Hye-Sook Han, Eunyong Ahn, Eun Seo Park, Tom Huh, Seri Choi, Yongmin Kwon, Byeong Hun Choi, Jueun Lee, Yoon Ha Choi, Yujin L. Jeong, Gwang Bin Lee, Minji Kim, Je Kyung Seong, Hyun Mu Shin, Hang-Rae Kim, Myeong Hee Moon, Jong Kyoung Kim, Geum-Sook Hwang, S
    Nature Aging.2023; 3(8): 982.     CrossRef
  • Exploring the diagnostic value, prognostic value, and biological functions of NPC gene family members in hepatocellular carcinoma based on a multi-omics analysis
    Keheng Chen, Xin Zhang, Huixin Peng, Fengdie Huang, Guangyu Sun, Qijiang Xu, Lusheng Liao, Zhiyong Xing, Yanping Zhong, Zhichao Fang, Meihua Liao, Shihua Luo, Wencheng Chen, Mingyou Dong
    Functional & Integrative Genomics.2023;[Epub]     CrossRef
  • MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
    Hao Sun, Jongsook Kim Kemper
    Experimental & Molecular Medicine.2023; 55(9): 1974.     CrossRef
  • Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice
    Miaomiao Du, Xueyun Li, Fangyi Xiao, Yinxu Fu, Yu Shi, Sihan Guo, Lifang Chen, Lu Shen, Lan Wang, Huang Cheng, Hao Li, Anran Xie, Yaping Zhou, Kaiqiang Yang, Hezhi Fang, Jianxin Lyu, Qiongya Zhao
    Metabolism.2022; 134: 155244.     CrossRef
  • cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
    Muhammad Bilal Ahmed, Abdullah A. A. Alghamdi, Salman Ul Islam, Joon-Seok Lee, Young-Sup Lee
    Cells.2022; 11(13): 2020.     CrossRef
  • Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity
    Aijun Qiao, Wenxia Ma, Ying Jiang, Chaoshan Han, Baolong Yan, Junlan Zhou, Gangjian Qin
    International Journal of Molecular Sciences.2022; 23(19): 11469.     CrossRef
  • The Role of Small Heterodimer Partner-Interacting Leucine Zipper (SMILE) as a Transcriptional Corepressor in Hepatic Glucose and Lipid Metabolism
    Woo-Ram Park, Byungyoon Choi, Nanthini Sadasivam, Don-Kyu Kim
    Trends in Agriculture & Life Sciences.2022; 60: 7.     CrossRef
  • AMPK Localization: A Key to Differential Energy Regulation
    Qonita Afinanisa, Min Kyung Cho, Hyun-A Seong
    International Journal of Molecular Sciences.2021; 22(20): 10921.     CrossRef
Resistin in Rodents and Humans
Hyeong Kyu Park, Rexford S. Ahima
Diabetes Metab J. 2013;37(6):404-414.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.404
  • 5,619 View
  • 54 Download
  • 122 Crossref
AbstractAbstract PDFPubReader   

Obesity is characterized by excess accumulation of lipids in adipose tissue and other organs, and chronic inflammation associated with insulin resistance and an increased risk of type 2 diabetes. Obesity, type 2 diabetes, and cardiovascular diseases are major health concerns. Resistin was first discovered as an adipose-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents. Adipocyte-derived resistin is increased in obese rodents and strongly related to insulin resistance. However, in contrast to rodents, resistin is expressed and secreted from macrophages in humans and is increased in inflammatory conditions. Some studies have also suggested an association between increased resistin levels and insulin resistance, diabetes and cardiovascular disease. Genetic studies have provided additional evidence for a role of resistin in insulin resistance and inflammation. Resistin appears to mediate the pathogenesis of atherosclerosis by promoting endothelial dysfunction, vascular smooth muscle cell proliferation, arterial inflammation, and formation of foam cells. Indeed, resistin is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. There is also growing evidence that elevated resistin is associated with the development of heart failure. This review will focus on the biology of resistin in rodents and humans, and evidence linking resistin with type 2 diabetes, atherosclerosis, and cardiovascular disease.

Citations

Citations to this article as recorded by  
  • Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis
    Manupati Srikanth, Mahaboobkhan Rasool
    Immunological Investigations.2024; 53(2): 115.     CrossRef
  • MHO or MUO? White adipose tissue remodeling
    Jing Yi Zhao, Li Juan Zhou, Kai Le Ma, Rui Hao, Min Li
    Obesity Reviews.2024;[Epub]     CrossRef
  • Resistin in endocrine pancreas of sheep: Presence and expression related to different diets
    Margherita Maranesi, Elisa Palmioli, Cecilia Dall'Aglio, Daniele Marini, Polina Anipchenko, Elena De Felice, Paola Scocco, Francesca Mercati
    General and Comparative Endocrinology.2024; 348: 114452.     CrossRef
  • Adipocytokines levels as potential biomarkers for discriminating patients with a diagnosis of depressive disorder from healthy controls
    Elżbieta Małujło-Balcerska, Tadeusz Pietras
    Journal of Psychiatric Research.2024; 171: 163.     CrossRef
  • Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
    Shiyun Zhang, Bingjie Zhang, Yuehua Liu, Li Li
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • The Role of Adipokines in the Control of Pituitary Functions
    Barbara Kaminska, Beata Kurowicka, Marta Kiezun, Kamil Dobrzyn, Katarzyna Kisielewska, Marlena Gudelska, Grzegorz Kopij, Karolina Szymanska, Barbara Zarzecka, Oguzhan Koker, Ewa Zaobidna, Nina Smolinska, Tadeusz Kaminski
    Animals.2024; 14(2): 353.     CrossRef
  • Adipokine imbalance and its role in the pathogenesis of novel coronavirus infection
    I. D. Bespalova, U. M. Mitrichenko, V. V. Kalyuzhin, E. S. Koroleva, Yu. I. Koshchavtseva, D. S. Romanov, D. E. Pershina
    Bulletin of Siberian Medicine.2024; 22(4): 164.     CrossRef
  • Association of adipokine levels with obesity in periodontal health and disease: A systematic review with meta‐analysis and meta‐regression
    Eswar Kandaswamy, Chun‐Teh Lee, Soumya Bardvalli Gururaj, Sachin Shivanaikar, Vinayak M. Joshi
    Journal of Periodontal Research.2024;[Epub]     CrossRef
  • Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction
    O. N. Dzhioeva, Yu. S. Timofeev, V. A. Metelskaya, A. A. Bogdanova, T. Yu. Vedenikin, O. M. Drapkina
    Cardiovascular Therapy and Prevention.2024; 23(3): 3928.     CrossRef
  • Association of maternal body composition and diet on breast milk hormones and neonatal growth during the first month of lactation
    David Ramiro-Cortijo, Pratibha Singh, Gloria Herranz Carrillo, Andrea Gila-Díaz, María A. Martín-Cabrejas, Camilia R. Martin, Silvia M. Arribas
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Upregulation of peripheral blood mononuclear cells resistin gene expression in severe obstructive sleep apnea and obstructive sleep apnea with coexisting type 2 diabetes mellitus
    Branislava Rajkov, Marija Zdravković, Ana Ninić, Milica Brajković, Slobodan Klašnja, Vera Gardijan, Lidija Memon, Jelena Munjas, Marija Mihajlović, Vesna Spasojević- Kalimanovska, Vojislav Radosavljević, Miron Sopić
    Sleep and Breathing.2023; 27(5): 2031.     CrossRef
  • Fat-to-heart crosstalk in health and disease
    Fleur Lodewijks, Timothy A. McKinsey, Emma L. Robinson
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19
    Thomas Grewal, Christa Buechler
    Biomedicines.2023; 11(5): 1302.     CrossRef
  • Role of adipokines in sarcopenia
    Wenhao Lu, Wenjie Feng, Jieyu Lai, Dongliang Yuan, Wenfeng Xiao, Yusheng Li
    Chinese Medical Journal.2023; 136(15): 1794.     CrossRef
  • Resistin, TNF-α, and microRNA 124-3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy
    Amin Monjezi, Azam Khedri, Mehrnoosh Zakerkish, Ghorban Mohammadzadeh
    International Journal of Diabetes in Developing Countries.2022; 42(1): 62.     CrossRef
  • Resistin in Urine and Breast Milk: Relation to Type of Feeding and Anthropometry at 1-Month
    Irena Santosa, Hiromichi Shoji, Kentaro Awata, Yoshiteru Arai, Hiroki Suganuma, Toshiaki Shimizu
    Pediatric Reports.2022; 14(1): 86.     CrossRef
  • High Serum Levels of Resistin is Associated With Acute Cerebral Infarction
    Kee Ook Lee, Kyung-Yul Lee, Cheol-Young Lee, Ji Hoon Kim, Jaeku Kang, Hoi Young Lee, Sang-Jun Na, Seung-Hun Oh, Ji Hoe Heo
    The Neurologist.2022; 27(2): 41.     CrossRef
  • Resistin production does not affect outcomes in a mouse model of acute surgical sepsis
    Anthony S. Bonavia, Zissis C. Chroneos, Victor Ruiz-Velasco, Charles H. Lang, Partha Mukhopadhyay
    PLOS ONE.2022; 17(3): e0265241.     CrossRef
  • Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population
    Iman Akhlaghipour, Amir Reza Bina, Mohammad Reza Mogharrabi, Ali Fanoodi, Amir Reza Ebrahimian, Soroush Khojasteh Kaffash, Atefeh Babazadeh Baghan, Mohammad Erfan Khorashadizadeh, Negin Taghehchian, Meysam Moghbeli
    Human Genomics.2022;[Epub]     CrossRef
  • Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease
    Hsin-Hua Chou, Lung-An Hsu, Jyh-Ming Jimmy Juang, Fu-Tien Chiang, Ming-Sheng Teng, Semon Wu, Yu-Lin Ko
    International Journal of Molecular Sciences.2022; 23(8): 4292.     CrossRef
  • Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease
    Katharine M. Lodge, Arlette Vassallo, Bin Liu, Merete Long, Zhen Tong, Paul R. Newby, Danya Agha-Jaffar, Koralia Paschalaki, Clara E. Green, Kylie B. R. Belchamber, Victoria C. Ridger, Robert A. Stockley, Elizabeth Sapey, Charlotte Summers, Andrew S. Cowb
    American Journal of Respiratory and Critical Care Medicine.2022; 205(8): 903.     CrossRef
  • The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
    Klaudia Parafiniuk, Wiktoria Skiba, Anna Pawłowska, Dorota Suszczyk, Aleksandra Maciejczyk, Iwona Wertel
    Biomedicines.2022; 10(4): 920.     CrossRef
  • Resistin Modulates Low-Density Lipoprotein Cholesterol Uptake in Human Placental Explants via PCSK9
    Sonia Nava-Salazar, Arturo Flores-Pliego, Giovanni Pérez-Martínez, Sandra Parra-Hernández, America Vanoye-Carlo, Francisco Ibarguengoitia-Ochoa, Otilia Perichart-Perera, Enrique Reyes-Muñoz, Juan Mario Solis-Paredes, Salvador Espino y Sosa, Guadalupe Estr
    Reproductive Sciences.2022; 29(11): 3242.     CrossRef
  • Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
    Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Javed Iqbal Wani, Zia Ul Sabah, Mohammed Jeelani, Vijaya Marakala, Shahzada Khalid Sohail, Mohamed O’haj, Muffarah Hamid Alharthi, Mohannad Mohammad S. Alamri
    Journal of Personalized Medicine.2022; 12(5): 735.     CrossRef
  • Immune system and sarcopenia: Presented relationship and future perspective
    Xuzhi Zhang, Hengzhen Li, Miao He, Jingyu Wang, Yuxiang Wu, Yusheng Li
    Experimental Gerontology.2022; 164: 111823.     CrossRef
  • Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes
    Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Giuseppe Palma, Isabella Calderoni, Edoardo Siciliano, Pasquale Lops, Francesco Giorgino, Annalisa Natalicchio
    International Journal of Molecular Sciences.2022; 23(10): 5522.     CrossRef
  • Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease
    Risa Wakiya, Kiyo Ueeda, Hiromi Shimada, Shusaku Nakashima, Tomohiro Kameda, Nobuyuki Miyatake, Mikiya Kato, Taichi Miyagi, Koichi Sugihara, Mao Mizusaki, Rina Mino, Norimitsu Kadowaki, Hiroaki Dobashi
    Clinical Rheumatology.2022; 41(11): 3345.     CrossRef
  • Can soy isoflavones in combination with soy protein change serum concentration of adiponectin and resistin? A systematic review and meta‐analysis on randomized clinical trials
    Mitra Hariri, Bahareh Amirkalali, Ensiyeh Mollanoroozy, Ali Gholami
    Food Science & Nutrition.2022; 10(12): 4126.     CrossRef
  • Adipokines: Deciphering the cardiovascular signature of adipose tissue
    Joseph C. Galley, Shubhnita Singh, Wanessa M.C. Awata, Juliano V. Alves, Thiago Bruder-Nascimento
    Biochemical Pharmacology.2022; 206: 115324.     CrossRef
  • Evaluation of the Anti-Obesity Effect of Zeaxanthin and Exercise in HFD-Induced Obese Rats
    Mona Al-thepyani, Salha Algarni, Hana Gashlan, Mohamed Elzubier, Lina Baz
    Nutrients.2022; 14(23): 4944.     CrossRef
  • Single High-Dose Vitamin D Supplementation as an Approach for Reducing Ultramarathon-Induced Inflammation: A Double-Blind Randomized Controlled Trial
    Jan Mieszkowski, Andżelika Borkowska, Błażej Stankiewicz, Andrzej Kochanowicz, Bartłomiej Niespodziński, Marcin Surmiak, Tomasz Waldziński, Rafał Rola, Miroslav Petr, Jędrzej Antosiewicz
    Nutrients.2021; 13(4): 1280.     CrossRef
  • Resistin mitigates stemness and metabolic profile of human adipose-derived mesenchymal stem cells via insulin resistance
    Komal Rawal, Kishan M. Purohit, Tushar P. Patel, Neeta Karont, Sarita Gupta
    Cytokine.2021; 138: 155374.     CrossRef
  • Resistin is co-secreted with adiponectin in white mouse adipocytes
    Saliha Musovic, Man Mohan Shrestha, Ali M. Komai, Charlotta S. Olofsson
    Biochemical and Biophysical Research Communications.2021; 534: 707.     CrossRef
  • Resistin: Potential biomarker and therapeutic target in atherosclerosis
    Li Zhou, Jun-Yi Li, Ping-Ping He, Xiao-Hua Yu, Chao-Ke Tang
    Clinica Chimica Acta.2021; 512: 84.     CrossRef
  • The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study
    Ziba Majidi, Solaleh Emamgholipour, Abolfazl Omidifar, Soheil Rahmani Fard, Hossein Poustchi, Mehrnoosh Shanaki
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
  • Corylin reduces obesity and insulin resistance and promotes adipose tissue browning through SIRT-1 and β3-AR activation
    Chin-Chuan Chen, Chen-Hsin Kuo, Yann-Lii Leu, Shu-Huei Wang
    Pharmacological Research.2021; 164: 105291.     CrossRef
  • A Focused Review of the Metabolic Side-Effects of Clozapine
    Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, William J. Panenka, William G. Honer, Alasdair M. Barr
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
    Antonio J. López-Gambero, Cristina Rosell-Valle, Dina Medina-Vera, Juan Antonio Navarro, Antonio Vargas, Patricia Rivera, Carlos Sanjuan, Fernando Rodríguez de Fonseca, Juan Suárez
    International Journal of Molecular Sciences.2021; 22(10): 5365.     CrossRef
  • Resistin in pregnancy: Analysis of determinants in pairs of umbilical cord blood and maternal serum
    Anne Floeck, Nina Ferrari, Christine Joisten, Maria T. Puth, Brigitte Strizek, Ramona Dolscheid-Pommerich, Ulrich Gembruch, Waltraut M. Merz
    Cytokine: X.2021; 3(2): 100052.     CrossRef
  • Is resistin the master link between inflammation and inflammation-related chronic diseases?
    Mohammed Taouis, Yacir Benomar
    Molecular and Cellular Endocrinology.2021; 533: 111341.     CrossRef
  • The dynamics of human bone marrow adipose tissue in response to feeding and fasting
    Pouneh K. Fazeli, Miriam A. Bredella, Gisela Pachon-Peña, Wenxiu Zhao, Xun Zhang, Alexander T. Faje, Megi Resulaj, Sai P. Polineni, Tara M. Holmes, Hang Lee, Elizabeth K. O’Donnell, Ormond A. MacDougald, Mark C. Horowitz, Clifford J. Rosen, Anne Klibanski
    JCI Insight.2021;[Epub]     CrossRef
  • Resistin: A journey from metabolism to cancer
    Ankita Deb, Bhavana Deshmukh, Pranay Ramteke, Firoz Khan Bhati, Manoj Kumar Bhat
    Translational Oncology.2021; 14(10): 101178.     CrossRef
  • Obesity is the basis of metabolic syndrome
    A. F. Verbovoy, N. I. Verbovaya, Yu. A. Dolgikh
    Obesity and metabolism.2021; 18(2): 142.     CrossRef
  • Human Milk Metabolic Hormones: Analytical Methods and Current Understanding
    Majed A. Suwaydi, Zoya Gridneva, Sharon L. Perrella, Mary E. Wlodek, Ching Tat Lai, Donna T. Geddes
    International Journal of Molecular Sciences.2021; 22(16): 8708.     CrossRef
  • Adipokines as Immune Cell Modulators in Multiple Sclerosis
    Merel Rijnsburger, Niek Djuric, Inge A. Mulder, Helga E. de Vries
    International Journal of Molecular Sciences.2021; 22(19): 10845.     CrossRef
  • The Role of Adipokines in Cardiovascular Pathology
    Valery Podzolkov , Anna Pokrovskaya, Ulyana Bazhanova , Tatyana Vargina , Svetlana Anatolievna Knyazeva , Daria Vanina
    Open Access Macedonian Journal of Medical Sciences.2021; 9(F): 794.     CrossRef
  • Measurement of Plasma Resistin Concentrations in Horses with Metabolic and Inflammatory Disorders
    Beatriz Fuentes-Romero, Alberto Muñoz-Prieto, José J. Cerón, María Martín-Cuervo, Manuel Iglesias-García, Escolástico Aguilera-Tejero, Elisa Díez-Castro
    Animals.2021; 12(1): 77.     CrossRef
  • EFFECT OF DIET AND EXERCISE-INDUCE WEIGHT LOSS ON LEVEL OF RESISTIN IN PATIENT WITH OBESITY
    О. I. Tokarenko, I. O. Andreieva, O. O. Tokarenko, M. M. Surmilo
    Modern medical technology.2021; (4): 11.     CrossRef
  • Alteration of gut microbiota affects expression of adiponectin and resistin through modifying DNA methylation in high-fat diet-induced obese mice
    Hongyang Yao, Chaonan Fan, Yuanyuan Lu, Xiuqin Fan, Lulu Xia, Ping Li, Rui Wang, Tiantian Tang, Yuanyuan Wang, Kemin Qi
    Genes & Nutrition.2020;[Epub]     CrossRef
  • Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin
    Zhian Sherzad Hayder, Zrar Saleem Kareem
    International Urology and Nephrology.2020; 52(4): 749.     CrossRef
  • Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation
    Ariane R. Pessentheiner, G. Michelle Ducasa, Philip L. S. M. Gordts
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Resistin Is Increased in Periodontal Cells and Tissues: In Vitro and In Vivo Studies
    Andressa V. B. Nogueira, Marjan Nokhbehsaim, Sema Tekin, Rafael S. de Molon, Luis C. Spolidorio, Svenja Memmert, Anna Damanaki, Andreas Jäger, Sigrun Eick, James Deschner, Joni A. Cirelli
    Mediators of Inflammation.2020; 2020: 1.     CrossRef
  • Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
    Alan Chait, Laura J. den Hartigh
    Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef
  • The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus
    Patrik Šimják, Kateřina Anderlová, Anna Cinkajzlová, Antonín Pařízek, Michal Kršek, Martin Haluzík
    Minerva Endocrinologica.2020;[Epub]     CrossRef
  • High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus
    Chenchen Wang, Xi Huang, Sai Tian, Rong Huang, Dan Guo, Hongyan Lin, Jiaqi Wang, Shaohua Wang
    Journal of Alzheimer's Disease.2020; 75(3): 807.     CrossRef
  • Resistin in metabolism, inflammation, and disease
    Deeksha Tripathi, Sashi Kant, Saurabh Pandey, Nasreen Z. Ehtesham
    The FEBS Journal.2020; 287(15): 3141.     CrossRef
  • Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
    Lucia Recinella, Giustino Orlando, Claudio Ferrante, Annalisa Chiavaroli, Luigi Brunetti, Sheila Leone
    Frontiers in Physiology.2020;[Epub]     CrossRef
  • Correlation of CCL18 with Levels of Adi-pokines in the Sera of Patients with Myocardial Infarction in a 6-Month Period: Case Series
    Atefeh GamarTalepoor, Ehsan Dowlatshahi, Mehrnoush Doroudchi
    Iranian South Medical Journal.2020; 23(3): 222.     CrossRef
  • The Mesentery, Systemic Inflammation, and Crohn’s Disease
    Edgardo D Rivera, John Calvin Coffey, Dara Walsh, Eli D Ehrenpreis
    Inflammatory Bowel Diseases.2019; 25(2): 226.     CrossRef
  • Resistin and adenylyl cyclase-associated protein 1 (CAP1) regulate the expression of genes related to insulin resistance in BNL CL.2 mouse liver cells
    Dimiter Avtanski, Karin Chen, Leonid Poretsky
    Data in Brief.2019; 25: 104112.     CrossRef
  • Proteomic profile of patients with atrial fibrillation undergoing cardiac surgery†
    Ilias P Doulamis, George Samanidis, Aspasia Tzani, Asier Antoranz, Anastasios Gkogkos, Panagiotis Konstantopoulos, Vaia Pliaka, Angeliki Minia, Leonidas G Alexopoulos, Despina N Perrea, Konstantinos Perreas
    Interactive CardioVascular and Thoracic Surgery.2019; 28(1): 94.     CrossRef
  • Angiotensin-(1-7), Adipokines and Inflammation
    Deborah de Farias Lelis, Daniela Fernanda de Freitas, Amanda Souto Machado, Thaísa Soares Crespo, Sérgio Henrique Sousa Santos
    Metabolism.2019; 95: 36.     CrossRef
  • New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
    Marta Olivera-Santa Catalina, Pedro C. Redondo, Maria P. Granados, Carlos Cantonero, Jose Sanchez-Collado, Letizia Albarran, Jose J. Lopez
    Current Medicinal Chemistry.2019; 26(22): 4119.     CrossRef
  • Myokine–adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome
    Adrian M. Gonzalez-Gil, Mariana Peschard-Franco, Elena C. Castillo, Gustavo Gutierrez-DelBosque, Victor Treviño, Christian Silva-Platas, Luisa Perez-Villarreal, Gerardo Garcia-Rivas, Leticia Elizondo-Montemayor
    Diabetology & Metabolic Syndrome.2019;[Epub]     CrossRef
  • Early Life Exposures to Perfluoroalkyl Substances in Relation to Adipokine Hormone Levels at Birth and During Childhood
    Colleen Shelly, Philippe Grandjean, Youssef Oulhote, Peter Plomgaard, Ruth Frikke-Schmidt, Flemming Nielsen, Denis Zmirou-Navier, Pal Weihe, Damaskini Valvi
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5338.     CrossRef
  • Overweight and obesity in childhood: Dietary, biochemical, inflammatory and lifestyle risk factors
    Samah R. Albataineh, Eman F. Badran, Reema F. Tayyem
    Obesity Medicine.2019; 15: 100112.     CrossRef
  • Effects of major adipokines and the −420 C > G resistin gene polymorphism on the long-term outcome of patients with acute ischemic stroke
    Stella Bouziana, Konstantinos Tziomalos, Antonis Goulas, Timoleon-Achilleas Vyzantiadis, Maria Papadopoulou, Athanasia Panderi, Apostolos Ι. Ηatzitolios
    International Journal of Neuroscience.2019; 129(10): 978.     CrossRef
  • The Complex Interactions Between Obesity, Metabolism and the Brain
    Romina María Uranga, Jeffrey Neil Keller
    Frontiers in Neuroscience.2019;[Epub]     CrossRef
  • Resistin: A reappraisal
    E. Acquarone, F. Monacelli, R. Borghi, A. Nencioni, P. Odetti
    Mechanisms of Ageing and Development.2019; 178: 46.     CrossRef
  • Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro‐inflammatory cytokines
    Melissa Emamalipour, Khaled Seidi, Ali Jahanban‐Esfahlan, Rana Jahanban‐Esfahlan
    Journal of Cellular Physiology.2019; 234(12): 21758.     CrossRef
  • Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis
    Vinod Chandran, Fatima Abji, Anthony V Perruccio, Rajiv Gandhi, Suzanne Li, Richard J Cook, Dafna D Gladman
    Annals of the Rheumatic Diseases.2019; 78(6): 796.     CrossRef
  • Telmisartan prevents diet-induced obesity and preserves leptin transport across the blood-brain barrier in high-fat diet-fed mice
    Franziska Schuster, Gianna Huber, Ines Stölting, Emily E. Wing, Kathrin Saar, Norbert Hübner, William A. Banks, Walter Raasch
    Pflügers Archiv - European Journal of Physiology.2018; 470(11): 1673.     CrossRef
  • Adipokines in human breast milk
    Juergen Kratzsch, Yoon Ju Bae, Wieland Kiess
    Best Practice & Research Clinical Endocrinology & Metabolism.2018; 32(1): 27.     CrossRef
  • Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk
    Krasimira Aleksandrova, Dariush Mozaffarian, Tobias Pischon
    Clinical Chemistry.2018; 64(1): 142.     CrossRef
  • Adipocytokine Involvement in Innate Immune Mechanisms
    Paulina Żelechowska, Elżbieta Kozłowska, Joanna Pastwińska, Justyna Agier, Ewa Brzezińska-Błaszczyk
    Journal of Interferon & Cytokine Research.2018; 38(12): 527.     CrossRef
  • The effect of a garlic supplement on the pro-inflammatory adipocytokines, resistin and tumor necrosis factor-alpha, and on pain severity, in overweight or obese women with knee osteoarthritis
    Sahar Dehghani, Elham Alipoor, Ahmad Salimzadeh, Mehdi Yaseri, Mostafa Hosseini, Christine Feinle-Bisset, Mohammad Javad Hosseinzadeh-Attar
    Phytomedicine.2018; 48: 70.     CrossRef
  • Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
    Xiao-Yan Qi, Shun-Lin Qu, Wen-Hao Xiong, Oren Rom, Lin Chang, Zhi-Sheng Jiang
    Cardiovascular Diabetology.2018;[Epub]     CrossRef
  • Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction
    Larisa-Diana Mocan Hognogi, Cerasela-Mihaela Goidescu, Anca-Daniela Farcaş
    Disease Markers.2018; 2018: 1.     CrossRef
  • Circulating fibroblast growth factor 21 in patients with liver cirrhosis
    Sabrina Krautbauer, Lisa Rein-Fischboeck, Elisabeth M Haberl, Rebekka Pohl, Reiner Wiest, Christa Buechler
    Clinical and Experimental Medicine.2018; 18(1): 63.     CrossRef
  • Association of Cord Blood Resistin with Neonatal Birth Weight and Gestational Age
    Shahnaz Pourarian, Saeed Fotouhikia, Forough Saki
    Journal of Comprehensive Pediatrics.2018;[Epub]     CrossRef
  • Major Adipokines and the −420C>G Resistin Gene Polymorphism as Predictors of Acute Ischemic Stroke Severity and In-Hospital Outcome
    Styliani D. Bouziana, Konstantinos Tziomalos, Antonios Goulas, Timoleon-Achilleas Vyzantiadis, Athanasia Panderi, Apostolos Ι. Ηatzitolios
    Journal of Stroke and Cerebrovascular Diseases.2018; 27(4): 963.     CrossRef
  • Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis
    Stephen P. J. Macdonald, Erika Bosio, Claire Neil, Glenn Arendts, Sally Burrows, Lisa Smart, Simon G. A. Brown, Daniel M. Fatovich
    Inflammation Research.2017; 66(7): 611.     CrossRef
  • Reference values for fasting serum resistin in healthy children and adolescents
    Ulrik Lausten-Thomsen, Michael Christiansen, Paula Louise Hedley, Tenna Ruest Haarmark Nielsen, Cilius Esmann Fonvig, Oluf Pedersen, Torben Hansen, Jens-Christian Holm
    Clinica Chimica Acta.2017; 469: 161.     CrossRef
  • Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis
    Alexander Kalinkovich, Gregory Livshits
    Ageing Research Reviews.2017; 35: 200.     CrossRef
  • Is There Any Relationship between Plasma 25-Hydroxyvitamin D3, Adipokine Profiles and Excessive Body Weight in Type 2 Diabetic Patients?
    Joanna Kocot, Piotr Dziemidok, Małgorzata Kiełczykowska, Jacek Kurzepa, Grzegorz Szcześniak, Irena Musik
    International Journal of Environmental Research and Public Health.2017; 15(1): 19.     CrossRef
  • Exogenous Adipokine Peptide Resistin Protects Against Focal Cerebral Ischemia/Reperfusion Injury in Mice
    Jiangtao Zhu, Di Wu, Chenyu Zhao, Man Luo, Ronald C. Hamdy, Balvin H. L. Chua, Xingshun Xu, Zhigang Miao
    Neurochemical Research.2017; 42(10): 2949.     CrossRef
  • Adipokines in Liver Cirrhosis
    Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis
    International Journal of Molecular Sciences.2017; 18(7): 1392.     CrossRef
  • The role of sex steroids in white adipose tissue adipocyte function
    A E Newell-Fugate
    Reproduction.2017; 153(4): R133.     CrossRef
  • Odanacatib Inhibits Resistin-induced Cardiomyocyte Hypertrophy Through the Inactivation of ERK Signaling Pathway
    Xian Zheng, Guanchang Cheng, Jianwei Luo, Qunhui Ye, Yongzhi Deng, Lin Wu
    International Journal of Pharmacology.2017; 13(2): 212.     CrossRef
  • Linking resistin, inflammation, and cardiometabolic diseases
    Hyeong Kyu Park, Mi Kyung Kwak, Hye Jeong Kim, Rexford S. Ahima
    The Korean Journal of Internal Medicine.2017; 32(2): 239.     CrossRef
  • Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
    M. Ruscica, A. Baragetti, A.L. Catapano, G.D. Norata
    Nutrition, Metabolism and Cardiovascular Diseases.2017; 27(5): 379.     CrossRef
  • Differences in Mean Levels of Maternal Resistin Serum between Early Onset Preeclampsia (EOPE) and Late Onset Preeclampsia (LOPE)
    Yusrawati ., P. Alfajra, R. Machmud
    Research Journal of Obstetrics and Gynecology.2016; 10(1): 1.     CrossRef
  • Secret talk between adipose tissue and central nervous system via secreted factors—an emerging frontier in the neurodegenerative research
    Avinash Parimisetty, Anne-Claire Dorsemans, Rana Awada, Palaniyandi Ravanan, Nicolas Diotel, Christian Lefebvre d’Hellencourt
    Journal of Neuroinflammation.2016;[Epub]     CrossRef
  • The role of adipokines in ischemic stroke risk stratification
    Styliani Bouziana, Konstantinos Tziomalos, Antonios Goulas, Apostolos Ι Ηatzitolios
    International Journal of Stroke.2016; 11(4): 389.     CrossRef
  • The endocrine function of human placenta: an overview
    Mariana A. Costa
    Reproductive BioMedicine Online.2016; 32(1): 14.     CrossRef
  • Ursolic acid plays a protective role in obesity-induced cardiovascular diseases
    Yu-Ting Lin, Ya-Mei Yu, Weng-Cheng Chang, Su-Yin Chiang, Hsu-Chin Chan, Ming-Fen Lee
    Canadian Journal of Physiology and Pharmacology.2016; 94(6): 627.     CrossRef
  • Determinants of body weight regulation in humans
    Milene Moehlecke, Luis Henrique Canani, Lucas Oliveira Junqueira e Silva, Manoel Roberto Maciel Trindade, Rogerio Friedman, Cristiane Bauermann Leitão
    Archives of Endocrinology and Metabolism.2016; 60(2): 152.     CrossRef
  • Sitagliptin decreases ventricular arrhythmias by attenuated glucose-dependent insulinotropic polypeptide (GIP)-dependent resistin signalling in infarcted rats
    Tsung-Ming Lee, Wei-Ting Chen, Nen-Chung Chang
    Bioscience Reports.2016;[Epub]     CrossRef
  • Les adipokines : état des lieux et nouveautés
    J.-P. Bastard, C. Bastard, S. Fellahi, C. Vatier, J. Capeau, B. Fève
    Obésité.2016; 11(3): 181.     CrossRef
  • Factors that promote macrophage homing to adipose tissue in metabolic syndrome
    Ishwarlal Jialal, Beverley Adams-Huet, Sridevi Devaraj
    Journal of Diabetes and its Complications.2016; 30(8): 1434.     CrossRef
  • Uncovering Factors Related to Pancreatic Beta-Cell Function
    Aoife M. Curran, Miriam F. Ryan, Elaine Drummond, Eileen R. Gibney, Michael J. Gibney, Helen M. Roche, Lorraine Brennan, Nigel Irwin
    PLOS ONE.2016; 11(8): e0161350.     CrossRef
  • Resistin’s, obesity and insulin resistance: the continuing disconnect between rodents and humans
    X. Huang, Z. Yang
    Journal of Endocrinological Investigation.2016; 39(6): 607.     CrossRef
  • Adipocytokines in renal transplant recipients
    Kristof Nagy, Shankar Prasad Nagaraju, Connie M. Rhee, Zoltan Mathe, Miklos Z. Molnar
    Clinical Kidney Journal.2016; 9(3): 359.     CrossRef
  • Endocrine alterations from concentric vs. eccentric muscle actions: A brief review
    Robert R. Kraemer, V. Daniel Castracane
    Metabolism.2015; 64(2): 190.     CrossRef
  • Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system
    Mark A. Barnes, Monica J. Carson, Meera G. Nair
    Cytokine.2015; 72(2): 210.     CrossRef
  • Local and serum levels of adipokines in patients with obesity after periodontal therapy: one‐year follow‐up
    Tiago Eduardo Dias Gonçalves, Glaucia Santos Zimmermann, Luciene Cristina Figueiredo, Monique de Carvalho Souza, Daniele Ferreira da Cruz, Marta Ferreira Bastos, Hélio Doyle Pereira da Silva, Poliana Mendes Duarte
    Journal of Clinical Periodontology.2015; 42(5): 431.     CrossRef
  • Newborn Adipokines and Birth Outcomes
    Edwina H. Yeung, Alexander C. McLain, Nancy Anderson, David Lawrence, Nansi S. Boghossian, Charlotte Druschel, Erin Bell
    Paediatric and Perinatal Epidemiology.2015; 29(4): 317.     CrossRef
  • The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats
    Márta Sárközy, Gergő Szűcs, Márton Pipicz, Ágnes Zvara, Katalin Éder, Veronika Fekete, Csilla Szűcs, Judit Bárkányi, Csaba Csonka, László G. Puskás, Csaba Kónya, Péter Ferdinandy, Tamás Csont
    Cardiovascular Diabetology.2015;[Epub]     CrossRef
  • Diet-induced variability of the resistin gene (Retn) transcript level and methylation profile in rats
    Joanna Nowacka-Woszuk, Ewa Pruszynska-Oszmalek, Maciej Szydlowski, Slawomir Sadkowski, Izabela Szczerbal
    BMC Genetics.2015;[Epub]     CrossRef
  • INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    A. T. Teplyakov, Sh. D. Akhmedov, T. Ye. Suslova, А. V. Andriyanova, A. V. Kuznetsova, N. V. Protopopova, V. V. Kalyuzhin, O. N. Nasanova
    Bulletin of Siberian Medicine.2015; 14(5): 73.     CrossRef
  • The Effects of a Single Developmentally Entrained Pulse of Testosterone in Female Neonatal Mice on Reproductive and Metabolic Functions in Adult Life
    Hyeran Jang, Shalender Bhasin, Tyler Guarneri, Carlo Serra, Mary Schneider, Mi-Jeong Lee, Wen Guo, Susan K. Fried, Karol Pencina, Ravi Jasuja
    Endocrinology.2015; 156(10): 3737.     CrossRef
  • The Resin fromProtium heptaphyllumPrevents High-Fat Diet-Induced Obesity in Mice: Scientific Evidence and Potential Mechanisms
    Karine Maria Martins Bezerra Carvalho, José Delano Barreto Marinho Filho, Tiago Sousa de Melo, Ana Jérsia Araújo, Josiane da Silva Quetz, Maria do Perpétuo Socorro Saldanha da Cunha, Karina Moura de Melo, Armenio Andre de Carvalho Almeida da Silva, Adrian
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • Evolution of the Vertebrate Resistin Gene Family
    Qingda Hu, Huanran Tan, David M. Irwin, Marc Robinson-Rechavi
    PLOS ONE.2015; 10(6): e0130188.     CrossRef
  • Obesity, adipokines and neuroinflammation
    Argel Aguilar-Valles, Wataru Inoue, Christoph Rummel, Giamal N. Luheshi
    Neuropharmacology.2015; 96: 124.     CrossRef
  • Adipokines at the crossroad between obesity and cardiovascular disease
    Filippo Molica, Sandrine Morel, Brenda Kwak, Françoise Rohner-Jeanrenaud, Sabine Steffens
    Thrombosis and Haemostasis.2015; 113(03): 553.     CrossRef
  • Resistin – 420 C/G polymorphism and serum resistin level in Iranian patients with gestational diabetes mellitus
    Mohammad Ali Takhshid, Zinab Zare
    Journal of Diabetes & Metabolic Disorders.2015;[Epub]     CrossRef
  • Ictal adipokines are associated with pain severity and treatment response in episodic migraine
    Nu Cindy Chai, Bizu Gelaye, Gretchen E. Tietjen, Paul D. Dash, Barbara A. Gower, Linda W. White, Thomas N. Ward, Ann I. Scher, B. Lee Peterlin
    Neurology.2015; 84(14): 1409.     CrossRef
  • Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
    Lindsay J. Spielman, Jonathan P. Little, Andis Klegeris
    Journal of Neuroimmunology.2014; 273(1-2): 8.     CrossRef
  • Wild Blueberries (Vaccinium myrtillus) Alleviate Inflammation and Hypertension Associated with Developing Obesity in Mice Fed with a High-Fat Diet
    Otto T. Mykkänen, Anne Huotari, Karl-Heinz Herzig, Thomas W. Dunlop, Hannu Mykkänen, Pirkka V. Kirjavainen, Michael Müller
    PLoS ONE.2014; 9(12): e114790.     CrossRef
  • Role of fat and adipokines in intestinal inflammation
    LeaI Kredel, Arvind Batra, Britta Siegmund
    Current Opinion in Gastroenterology.2014; 30(6): 559.     CrossRef
  • 13C metabolic flux analysis shows that resistin impairs the metabolic response to insulin in L6E9 myotubes
    Shirley Guzmán, Silvia Marin, Anibal Miranda, Vitaly A Selivanov, Josep J Centelles, Romain Harmancey, Fatima Smih, Annie Turkieh, Yves Durocher, Antonio Zorzano, Philippe Rouet, Marta Cascante
    BMC Systems Biology.2014;[Epub]     CrossRef
  • Bee Pollen Improves Muscle Protein and Energy Metabolism in Malnourished Old Rats through Interfering with the Mtor Signaling Pathway and Mitochondrial Activity
    Jérôme Salles, Nicolas Cardinault, Véronique Patrac, Alexandre Berry, Christophe Giraudet, Marie-Laure Collin, Audrey Chanet, Camille Tagliaferri, Philippe Denis, Corinne Pouyet, Yves Boirie, Stéphane Walrand
    Nutrients.2014; 6(12): 5500.     CrossRef
Original Article
Association of Estrogen Receptor α Genes PvuII and XbaI Polymorphisms with Type 2 Diabetes Mellitus in the Inpatient Population of a Hospital in Southern Iran
Farzaneh Mohammadi, Mohammad Pourahmadi, Mohadeseh Mosalanejad, Houshang Jamali, Mohamed Amin Ghobadifar, Saeideh Erfanian
Diabetes Metab J. 2013;37(4):270-277.   Published online August 14, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.4.270
  • 3,427 View
  • 36 Download
  • 4 Crossref
AbstractAbstract PDFPubReader   
Background

Estrogen plays a fundamental role in the pathogenesis of type 2 diabetes mellitus (T2DM). Very few studies have shown the association between estrogen receptor α (ERα), PvuII and XbaI gene polymorphisms with T2DM in both men and women. We evaluated the hypothesis that PvuII and XbaI polymorphisms of ERα gene may be associated with T2DM in adult.

Methods

From spring of 2010 to the fall of 2011, a case-control study was performed at clinical centers of Jahrom University of Medical Sciences. We included 174 patients with T2DM including men and women and 174 age, sex, and body mass index frequency-matched health controls. We analyzed the PvuII and XbaI polymorphisms of ERα by using the polymerase chain reaction-based restriction fragment length polymorphism method.

Results

No significant differences between demographic characteristics of control and patients groups were observed. Allele frequencies of both PvuII and XbaI polymorphisms were significantly different between patients and control subjects (P=0.014 vs. P=0.002, respectively). When the group was separated into women and men, logistic regression analysis of genotype distribution of PvuII (pp vs. Pp+PP) in both sexes revealed that there was no significant association of PvuII genotype with men (odds ratio [OR], 1.67; confidence interval [CI], 0.86 to 3.28; P=0.89) and women (OR, 0.96; CI, 0.53 to 1.74; P=0.12).

Conclusion

PvuII and XbaI polymorphisms in ERα are related with T2DM in the inpatient population.

Citations

Citations to this article as recorded by  
  • Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population
    Iman Akhlaghipour, Amir Reza Bina, Mohammad Reza Mogharrabi, Ali Fanoodi, Amir Reza Ebrahimian, Soroush Khojasteh Kaffash, Atefeh Babazadeh Baghan, Mohammad Erfan Khorashadizadeh, Negin Taghehchian, Meysam Moghbeli
    Human Genomics.2022;[Epub]     CrossRef
  • Estrogen receptor 1 gene polymorphisms (PvuII and XbaI) are associated with type 2 diabetes in Palestinian women
    Suheir Ereqat, Stéphane Cauchi, Khaled Eweidat, Muawiyah Elqadi, Abedelmajeed Nasereddin
    PeerJ.2019; 7: e7164.     CrossRef
  • Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies
    Mehrnoosh Khodaeian, Samaneh Enayati, Ozra Tabatabaei-Malazy, Mahsa M. Amoli
    Journal of Diabetes Research.2015; 2015: 1.     CrossRef
  • Genetic polymorphism of estrogen receptor alpha gene in Egyptian women with type II diabetes mellitus
    Tarek M.K. Motawi, Mahmoud A. El-Rehany, Sherine M. Rizk, Maggie M. Ramzy, Doaa M. el-Roby
    Meta Gene.2015; 6: 36.     CrossRef
Sulwon Lecture 2011
Post-Renal Transplant Diabetes Mellitus in Korean Subjects: Superimposition of Transplant-Related Immunosuppressant Factors on Genetic and Type 2 Diabetic Risk Factors
Hyun Chul Lee
Diabetes Metab J. 2012;36(3):199-206.   Published online June 14, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.3.199
  • 3,612 View
  • 31 Download
  • 9 Crossref
AbstractAbstract PDFPubReader   

Postrenal transplantation diabetes mellitus (PTDM), or new-onset diabetes after organ transplantation, is an important chronic transplant-associated complication. Similar to type 2 diabetes, decreased insulin secretion and increased insulin resistance are important to the pathophysiologic mechanism behind the development of PTDM. However, β-cell dysfunction rather than insulin resistance seems to be a greater contributing factor in the development of PTDM. Increased age, family history of diabetes, ethnicity, genetic variation, obesity, and hepatitis C are partially accountable for an increased underlying risk of PTDM in renal allograft recipients. In addition, the use of and kinds of immunosuppressive agents are key transplant-associated risk factors. Recently, a number of genetic variants or polymorphisms susceptible to immunosuppressants have been reported to be associated with calcineurin inhibition-induced β-cell dysfunction. The identification of high risk factors of PTDM would help prevent PTDM and improve long-term patient outcomes by allowing for personalized immunosuppressant regimens and by managing cardiovascular risk factors.

Citations

Citations to this article as recorded by  
  • Risk Factors Related to New-Onset Diabetes after Renal Transplantation in Patients of a High Complexity University Hospital in Colombia, 20 Years of Experience
    Guillermo E. Guzmán, Angela M. Victoria, Isabella Ramos, Alejandro Maldonado, Eliana Manzi, Juan F. Contreras-Valero, Liliana Mesa, Johanna Schweineberg, Juan G. Posada, Jorge I. Villegas, Luis A. Caicedo, Carlos E. Durán
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Synthesis of Fructose Biosensors and Progressing Their Efficiency Using Californium Colloidal Nanoparticles for Detecting Fructose and Triglycerides
    Alireza Heidari
    Advanced Science, Engineering and Medicine.2020; 12(8): 1002.     CrossRef
  • Comparison of Glucose Tolerance between Kidney Transplant Recipients and Healthy Controls
    Hisao Shimada, Junji Uchida, Shunji Nishide, Kazuya Kabei, Akihiro Kosoku, Keiko Maeda, Tomoaki Iwai, Toshihide Naganuma, Yoshiaki Takemoto, Tatsuya Nakatani
    Journal of Clinical Medicine.2019; 8(7): 920.     CrossRef
  • Diabètes post-transplantation rénale
    Danièle Dubois-Laforgue
    Néphrologie & Thérapeutique.2017; 13: S137.     CrossRef
  • Risk assessment and management of post-transplant diabetes mellitus
    Eugene Han, Myoung Soo Kim, Yu Seun Kim, Eun Seok Kang
    Metabolism.2016; 65(10): 1559.     CrossRef
  • Renal posttransplantation diabetes mellitus: An overview
    Ana Laura Pimentel, Andrea Carla Bauer, Joíza Lins Camargo
    Clinica Chimica Acta.2015; 450: 327.     CrossRef
  • HMG CoA Reductase Inhibitor Treatment Induces Dysglycemia in Renal Allograft Recipients
    Eun Yeong Choe, Hye Jin Wang, Obin Kwon, Yongin Cho, Kyu Ha Huh, Myoung Soo Kim, Yu Seun Kim, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Eun Seok Kang
    Transplantation.2014; 97(4): 419.     CrossRef
  • Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels
    Yongin Cho, Min Jung Lee, Eun Yeong Choe, Chang Hee Jung, Dong Jin Joo, Myoung Soo Kim, Bong Soo Cha, Joong-Yeol Park, Eun Seok Kang
    Liver Transplantation.2014; 20(5): 557.     CrossRef
  • Post-Transplant Diabetes Mellitus: Is It Associated With Poor Allograft Outcomes in Renal Transplants?
    J.Y. Choi, O.J. Kwon
    Transplantation Proceedings.2013; 45(8): 2892.     CrossRef
Reviews
Challenges in Diagnosing Type 1 Diabetes in Different Populations
Marian Rewers
Diabetes Metab J. 2012;36(2):90-97.   Published online April 17, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.2.90
  • 3,966 View
  • 48 Download
  • 33 Crossref
AbstractAbstract PDFPubReader   

Diabetes affects today an estimated 366 million people world-wide, including 20 million to 40 million of patients with type 1 diabetes (T1D). While T1D accounts for 5% to 20% of those with diabetes, it is associated with higher morbidity, mortality and health care cost than the more prevalent type 2 diabetes. Patients with T1D require exogenous insulin for survival and should be identified as soon as possible after diagnosis to avoid high morbidity due to a delay in insulin treatment. It is also important to present to the patient correct prognosis that differs by the type of diabetes. From the research point of view, correct classification should help to identify the etiologies and to develop specific prevention for T1D. This review summarizes evidence that may be helpful in diagnosing T1D in various ethnic groups. Challenges in interpretation of results commonly used to determine the type of diabetes are highlighted.

Citations

Citations to this article as recorded by  
  • Evaluation of Corneal Endothelium and Central Corneal Thickness in Children and Adolescents with Type 1 Diabetes
    Semra Tiryaki Demir, Ahmet Uçar, Gizem Kara Elitok, Sümeyra Keleş Yeşiltaş, Emine Betül Akbaş Özyürek, Saniye Üke Uzun
    Hamidiye Medical Journal.2023; 4(1): 50.     CrossRef
  • Analysis of Corneal and Lens Densitometry Changes in Patients With Type 1 Diabetes Mellitus
    Yusuf Cem Yilmaz, Serife Ciloglu Hayat, Sefik Can Ipek
    American Journal of Ophthalmology.2023; 254: 23.     CrossRef
  • Altered Prevalence of Pulp Diagnoses in Diabetes Mellitus Patients: A Retrospective Study
    Yandy Gonzalez Marrero, Yoshifumi Kobayashi, Mohammad Saqib Ihsan, Lisa A. Pilch, Liyaa Chen, Shuying Jiang, Yi Ye, Daniel H. Fine, Carla Y. Falcon, Paul A. Falcon, Craig S. Hirschberg, Emi Shimizu
    Journal of Endodontics.2022; 48(2): 208.     CrossRef
  • The relationship between GAD65 autoantibody and the risk of T1DM onset
    Elham Keshavarzi, Behnoud Baradaran Noveiry, Nima Rezaei
    Journal of Diabetes & Metabolic Disorders.2022; 21(2): 1935.     CrossRef
  • Ketosis-Prone Type 2 Diabetes (Flatbush Diabetes) in Remission: A Report of Two Cases
    Beisi Ji, SumathaChannapatna Suresh, Klynt Bally, Kamrun Naher, Mary A Banerji
    Cureus.2022;[Epub]     CrossRef
  • Analysis of immune cell components and immune-related gene expression profiles in peripheral blood of patients with type 1 diabetes mellitus
    Jian Lin, Yuanhua Lu, Bizhou Wang, Ping Jiao, Jie Ma
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies
    C. J. Padoa, P. Rheeder, F. J. Pirie, A. A. Motala, J. C. van Dyk, N. J. Crowther
    Diabetic Medicine.2020; 37(12): 2067.     CrossRef
  • Evaluation of retinal neurovascular structures by optical coherence tomography and optical coherence tomography angiography in children and adolescents with type 1 diabetes mellitus without clinical sign of diabetic retinopathy
    Semra Tiryaki Demir, Ahmet Ucar, Gizem Kara Elitok, Mehmet Egemen Karatas, Murat Karapapak, Oguz Kaan Kutucu, Saniye Uke Uzun, Dilek Guven
    Graefe's Archive for Clinical and Experimental Ophthalmology.2020; 258(11): 2363.     CrossRef
  • A Genome-Wide Analysis of Long Noncoding RNAs in Circulating Leukocytes and Their Differential Expression in Type 1 Diabetes Patients
    Yihan Liu, Xiaoming Du, Jia Cui, Changlong Li, Meng Guo, Jianyi Lv, Xin Liu, Jingtao Dou, Xiaoyan Du, Hongjuan Fang, Zhenwen Chen, Bernd Stratmann
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Uncommon Presentations of Diabetes: Zebras in the Herd
    Karen L. Shidler, Lisa R. Letourneau, Lucia M. Novak
    Clinical Diabetes.2020; 38(1): 78.     CrossRef
  • Changes in Retinal Microcirculation Precede the Clinical Onset of Diabetic Retinopathy in Children With Type 1 Diabetes Mellitus
    Merve Inanc, Kemal Tekin, Hasan Kiziltoprak, Servan Ozalkak, Sibel Doguizi, Zehra Aycan
    American Journal of Ophthalmology.2019; 207: 37.     CrossRef
  • Autoimmune signatures for prediction and diagnosis of autoimmune diabetes in Kuwait
    Mohamed Jahromi, Fahd Al-Mulla, Ebaa Al-Ozairi
    Autoimmunity Reviews.2019; 18(6): 642.     CrossRef
  • Human Leukocyte Antigen (HLA) and Islet Autoantibodies Are Tools to Characterize Type 1 Diabetes in Arab Countries: Emphasis on Kuwait
    Mohamed Jahromi, Ebaa Al-Ozairi
    Disease Markers.2019; 2019: 1.     CrossRef
  • Complete loss of insulin secretion capacity in type 1A diabetes patients during long‐term follow up
    Sae Uno, Akihisa Imagawa, Junji Kozawa, Kenji Fukui, Hiromi Iwahashi, Iichiro Shimomura
    Journal of Diabetes Investigation.2018; 9(4): 806.     CrossRef
  • Incidence of type 1 diabetes has doubled in Kuwaiti children 0-14 years over the last 20 years
    Azza A. Shaltout, Deborah Wake, Thangavel A. Thanaraj, Dina M. Omar, Dalia Al-AbdulRazzaq, Arshad Channanath, Hessa AlKandari, Majedah Abdulrasoul, Sophie Miller, Nicholas Conway, Jaakko Tuomilehto, Lena Davidsson
    Pediatric Diabetes.2017; 18(8): 761.     CrossRef
  • Objective Evaluation of Corneal and Lens Clarity in Children With Type 1 Diabetes Mellitus
    Kemal Tekin, Merve Inanc, Erdal Kurnaz, Elvan Bayramoglu, Emre Aydemir, Mustafa Koc, Zehra Aycan
    American Journal of Ophthalmology.2017; 179: 190.     CrossRef
  • Differential association of body mass index on glycemic control in type 1 diabetes
    Eun Young Lee, Yong‐ho Lee, Sang‐Man Jin, Hae Kyung Yang, Chang Hee Jung, Cheol‐Young Park, Jae Hyoung Cho, Woo Je Lee, Byung‐Wan Lee, Jae Hyeon Kim
    Diabetes/Metabolism Research and Reviews.2017;[Epub]     CrossRef
  • Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices
    Shang Song, Shuvo Roy
    Biotechnology and Bioengineering.2016; 113(7): 1381.     CrossRef
  • Covariation of the Incidence of Type 1 Diabetes with Country Characteristics Available in Public Databases
    Paula Andrea Diaz-Valencia, Pierre Bougnères, Alain-Jacques Valleron
    PLOS ONE.2015; 10(2): e0118298.     CrossRef
  • Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
    Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Cardiovascular Diabetology.2015;[Epub]     CrossRef
  • Lipid peroxidation and antioxidant protection in girls with type 1 diabetes mellitus during reproductive system development
    Lubov I. Kolesnikova, Marina A. Darenskaya, Natalia V. Semenova, Lyudmila A. Grebenkina, Larisa V. Suturina, Marya I. Dolgikh, Svetlana V. Gnusina
    Medicina.2015; 51(2): 107.     CrossRef
  • Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
    Eiji Kawasaki, Taro Maruyama, Akihisa Imagawa, Takuya Awata, Hiroshi Ikegami, Yasuko Uchigata, Haruhiko Osawa, Yumiko Kawabata, Tetsuro Kobayashi, Akira Shimada, Ikki Shimizu, Kazuma Takahashi, Masao Nagata, Hideichi Makino, Toshiaki Hanafusa
    Journal of Diabetes Investigation.2014; 5(1): 115.     CrossRef
  • The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
    Wonjin Kim, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2014; 38(6): 456.     CrossRef
  • Diabetes mellitus associada à desnutrição proteica: realidade ou ficção?
    Ana Rita Caldas, André Couto Carvalho, Anabela Giestas, Marta Almeida Ferreira, Cláudia Amaral, Cláudia Freitas, Maria Helena Cardoso
    Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo.2014; 9(1): 79.     CrossRef
  • Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012)
    Eiji Kawasaki, Taro Maruyama, Akihisa Imagawa, Takuya Awata, Hiroshi Ikegami, Yasuko Uchigata, Haruhiko Osawa, Yumiko Kawabata, Tetsuro Kobayashi, Akira Shimada, Ikki Shimizu, Kazuma Takahashi, Masao Nagata, Hideichi Makino, Toshiaki Hanafusa
    Diabetology International.2013; 4(4): 221.     CrossRef
  • Phenylmethimazole Suppresses dsRNA-Induced Cytotoxicity and Inflammatory Cytokines in Murine Pancreatic Beta Cells and Blocks Viral Acceleration of Type 1 Diabetes in NOD Mice
    Kelly McCall, Martin Schmerr, Jean Thuma, Calvin James, Maria Courreges, Fabian Benencia, Ramiro Malgor, Frank Schwartz
    Molecules.2013; 18(4): 3841.     CrossRef
  • Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptide
    Xia Li, Gan Huang, Jian Lin, Lin Yang, Zhiguang Zhou
    BMC Endocrine Disorders.2013;[Epub]     CrossRef
  • The Emerging Global Epidemic of Type 1 Diabetes
    Jaakko Tuomilehto
    Current Diabetes Reports.2013; 13(6): 795.     CrossRef
  • Clinical characteristics and insulin independence of Koreans with new‐onset type 2 diabetes presenting with diabetic ketoacidosis
    H. Seok, C. H. Jung, S. W. Kim, M. J. Lee, W. J. Lee, J. H. Kim, B‐W. Lee
    Diabetes/Metabolism Research and Reviews.2013; 29(6): 507.     CrossRef
  • Diabetes mellitus and inflammatory pulpal and periapical disease: a review
    S. M. F. Lima, D. C. Grisi, E. M. Kogawa, O. L. Franco, V. C. Peixoto, J. F. Gonçalves‐Júnior, M. P. Arruda, T. M. B. Rezende
    International Endodontic Journal.2013; 46(8): 700.     CrossRef
  • UM OLHAR SOBRE O DIABETES NA INFÂNCIA E NA JUVENTUDE: NEM TODOS SÃO TIPO 1
    Mauren Isfer ANGHEBEM-OLIVEIRA
    Infarma - Ciências Farmacêuticas.2013; 25(4): 206.     CrossRef
  • Proteome‐base biomarkers in diabetes mellitus: Progress on biofluids' protein profiling using mass spectrometry
    Ana Isabel Padrão, Rita Ferreira, Rui Vitorino, Francisco Amado
    PROTEOMICS – Clinical Applications.2012; 6(9-10): 447.     CrossRef
  • Diabetes mellitus: formas de presentación clínica y diagnóstico diferencial de la hiperglucemia en la infancia y adolescencia
    Ó. Rubio Cabezas, J. Argente
    Anales de Pediatría.2012; 77(5): 344.e1.     CrossRef
The Importance of Global Studies of the Genetics of Type 2 Diabetes
Mark I. McCarthy
Diabetes Metab J. 2011;35(2):91-100.   Published online April 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.2.91
  • 4,142 View
  • 29 Download
  • 11 Crossref
AbstractAbstract PDFPubReader   

Genome wide association analyses have revealed large numbers of common variants influencing predisposition to type 2 diabetes and related phenotypes. These studies have predominantly featured European populations, but are now being extended to samples from a wider range of ethnic groups. The transethnic analysis of association data is already providing insights into the genetic, molecular and biological causes of diabetes, and the relevance of such studies will increase as human discovery genetics increasingly moves towards sequencing-based approaches and a focus on low frequency and rare variants.

Citations

Citations to this article as recorded by  
  • Validation and genetic heritability estimation of known type 2 diabetes related variants in the Korean population
    Hye-Mi Jang, Mi Yeong Hwang, Bong-Jo Kim, Young Jin Kim
    Genomics & Informatics.2021; 19(4): e37.     CrossRef
  • Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis
    Matthew Dapas, Frederick T. J. Lin, Girish N. Nadkarni, Ryan Sisk, Richard S. Legro, Margrit Urbanek, M. Geoffrey Hayes, Andrea Dunaif, Jenny E. Myers
    PLOS Medicine.2020; 17(6): e1003132.     CrossRef
  • Association of a genetic variant of the ZPR1 zinc finger gene with type 2 diabetes mellitus
    FUMITAKA TOKORO, REIKO MATSUOKA, SHINTARO ABE, MASAZUMI ARAI, TOSHIYUKI NODA, SACHIRO WATANABE, HIDEKI HORIBE, TETSUO FUJIMAKI, MITSUTOSHI OGURI, KIMIHIKO KATO, SHINYA MINATOGUCHI, YOSHIJI YAMADA
    Biomedical Reports.2015; 3(1): 88.     CrossRef
  • Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Glycaemic Traits
    Letizia Marullo, Julia S. El-Sayed Moustafa, Inga Prokopenko
    Current Diabetes Reports.2014;[Epub]     CrossRef
  • Towards Virtual Knowledge Broker services for semantic integration of life science literature and data sources
    Ian Harrow, Wendy Filsell, Peter Woollard, Ian Dix, Michael Braxenthaler, Richard Gedye, David Hoole, Richard Kidd, Jabe Wilson, Dietrich Rebholz-Schuhmann
    Drug Discovery Today.2013; 18(9-10): 428.     CrossRef
  • Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21
    Rubina Tabassum, Ganesh Chauhan, Om Prakash Dwivedi, Anubha Mahajan, Alok Jaiswal, Ismeet Kaur, Khushdeep Bandesh, Tejbir Singh, Benan John Mathai, Yogesh Pandey, Manickam Chidambaram, Amitabh Sharma, Sreenivas Chavali, Shantanu Sengupta, Lakshmi Ramakris
    Diabetes.2013; 62(3): 977.     CrossRef
  • A replication study of 19 GWAS-validated type 2 diabetes at-risk variants in the Lebanese population
    Wassim Y. Almawi, Rita Nemr, Sose H. Keleshian, Akram Echtay, Fabiola Lisa Saldanha, Fatima A. AlDoseri, Eddie Racoubian
    Diabetes Research and Clinical Practice.2013; 102(2): 117.     CrossRef
  • Single nucleotide polymorphisms in JAZF1 and BCL11A gene are nominally associated with type 2 diabetes in African-American families from the GENNID study
    Kurt A Langberg, Lijun Ma, Neeraj K Sharma, Craig L Hanis, Steven C Elbein, Sandra J Hasstedt, Swapan K Das
    Journal of Human Genetics.2012; 57(1): 57.     CrossRef
  • Typ-2-Diabetes-assoziierte Gene
    J. Kriebel, H. Grallert, T. Illig
    Der Diabetologe.2012; 8(1): 26.     CrossRef
  • Genomweite Assoziationsstudien (GWAS) — Möglichkeiten und Grenzen
    Jennifer Kriebel, Thomas Illig, Harald Grallert
    BIOspektrum.2012; 18(5): 508.     CrossRef
  • T2DM: Why Epigenetics?
    Delphine Fradin, Pierre Bougnères
    Journal of Nutrition and Metabolism.2011; 2011: 1.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal